Significance of systemic immune-inflammation index in the differential diagnosis of high- and low-grade gliomas.

•Biomarkers in circulation have become increasingly appreciated in the grading of gliomas.•The clinical value of systemic immune-inflammation index (SII) in gliomas has not been explored.•SII is an effective inflammatory marker in terms of distinguishing high- and low-grade gliomas preoperatively.